Détail de l'auteur
Auteur Ciafaloni E |
Documents disponibles écrits par cet auteur (65)



![]()
Medical management of muscle weakness in Duchenne muscular dystrophy
Rivera SR, Jhamb SK, Abdel-Hamid HZ, et al.
PLoS ONE, 2020, 15, 10
Revue : PLoS ONE, 15, 10 Titre : Medical management of muscle weakness in Duchenne muscular dystrophy Type de document : Article Auteurs : Rivera SR ; Jhamb SK ; Abdel-Hamid HZ ; Acsadi G ; Brandsema J ; Ciafaloni E ; Darras BT ; Iannaccone ST ; Konersman CG ; Kuntz NL ; McDonald CM ; Parsons JA ; Tesi Rocha C ; Zaidman CM ; Butterfield RJ ; Connolly AM ; Mathews KD Année de publication : 19/10/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 33075081 / DOI : 10.1371/journal.pone.0240687
N° Profil MNM : 2020102 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/33075081 Voir aussiAvis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Minimal manifestation status and prednisone withdrawal in the MGTX trial
Lee I, Kuo HC, Aban IB, et al.
Neurology, 2020
Revue : Neurology Titre : Minimal manifestation status and prednisone withdrawal in the MGTX trial Type de document : Article Auteurs : Lee I ; Kuo HC ; Aban IB ; Cutter GR ; McPherson T ; Kaminski HJ ; Sussman J ; Strobel P ; Oger J ; Cea G ; Heckmann JM ; Evoli A ; Nix W ; Ciafaloni E ; Antonini G ; Witoonpanich R ; King JO ; Beydoun SR ; Chalk CH ; Barboi AC ; Amato AA ; Shaibani AI ; Katirji B ; Lecky BRF ; Buckley C ; Vincent A ; Dias-Tosta E ; Yoshikawa H ; Waddington-Cruz M ; Pulley MT ; Rivner MH ; Kostera-Pruszczyk A ; Pascuzzi RM ; Jackson CE ; Verschuuren JJG ; Massey JM ; Kissel JT ; Werneck LC ; Benatar M ; Barohn RJ ; Tandan R ; Mozaffar T ; Conwit R ; Minisman G ; Sonett JR ; Wolfe GI Editeur : United States Année de publication : 07/2020 Langues : Anglais (eng) Lien associé : NCT00294658 Pubmed / DOI : Pubmed : 32611638 / DOI : 10.1212/WNL.0000000000010031
N° Profil MNM : 2020062 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32611638 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy
Kay DM, Stevens CF, Parker A, et al.
Genetics in medicine : official journal of the American College of Medical Genetics, 2020
Revue : Genetics in medicine : official journal of the American College of Medical Genetics Titre : Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy Type de document : Article Auteurs : Kay DM ; Stevens CF ; Parker A ; Saavedra-Matiz CA ; Sack V ; Chung WK ; Chiriboga CA ; Engelstad K ; Laureta E ; Farooq O ; Ciafaloni E ; Lee BH ; Malek S ; Treidler S ; Anziska Y ; Delfiner L ; Sakonju A ; Caggana M Editeur : United States Année de publication : 05/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32418989 / DOI : 10.1038/s41436-020-0824-3
N° Profil MNM : 2020052 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32418989 Voir aussi
SMA : l’expérience new-yorkaise du dépistage à la naissance
Urtizberea JA
2020
Correspondence on: "Discrepancy in Spinal Muscular Atrophy Incidence findings in newborn screening programs: the influence of carrier screening?" by Kay et al
Dangouloff T, Boemer F, Caberg JH, et al.
Genetics in medicine : official journal of the American College of Medical Genetics, 2020
Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Spinal muscular atrophy care in the COVID-19 pandemic era
Veerapandiyan A, Connolly AM, Finkel RS, et al.
Muscle & Nerve, 2020
Revue : Muscle & Nerve Titre : Spinal muscular atrophy care in the COVID-19 pandemic era Type de document : Article Auteurs : Veerapandiyan A, Auteur ; Connolly AM ; Finkel RS ; Arya K ; Mathews KD ; Smith EC ; Castro D ; Butterfield RJ ; Parsons JA ; Servais L ; Kuntz N ; Rao VK ; Brandsema JF ; Mercuri E ; Ciafaloni E Editeur : United States Année de publication : 04/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32329921 / DOI : 10.1002/mus.26903
N° Profil MNM : 2020042 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32329921 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic
Veerapandiyan A, Wagner KR, Apkon S, et al.
Muscle & Nerve, 2020
Revue : Muscle & Nerve Titre : The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic Type de document : Article Auteurs : Veerapandiyan A, Auteur ; Wagner KR ; Apkon S ; McDonald CM ; Mathews KD ; Parsons JA ; Wong BL ; Eichinger K ; Shieh PB ; Butterfield RJ ; Rao VK ; Smith EC ; Proud CM ; Connolly AM ; Ciafaloni E Editeur : United States Année de publication : 04/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32329920 / DOI : 10.1002/mus.26902
N° Profil MNM : 2020042 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32329920 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Spinal muscular atrophy and Farber disease due to ASAH1 variants: A case report
Lee BH, Mongiovi P, Levade T, et al.
American journal of medical genetics. Part A, 2020
Permalink![]()
Left ventricular dysfunction in Duchenne muscular dystrophy
James KA, Gralla J, Ridall LA, et al.
Cardiology in the young, 2020
Permalink![]()
Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment
Ke Q, Zhao ZY, Griggs R, et al.
World journal of pediatrics : WJP, 2020, 13, 3, p 197
Permalink![]()
Myasthenia Gravis and Congenital Myasthenic Syndromes
Ciafaloni E
Continuum (Minneapolis, Minn.), 2019, 25, 6, p 1767
Permalink![]()
Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience
Veerapandiyan A, Eichinger K, Guntrum D, et al.
Muscle & Nerve, 2019
Permalink![]()
Combination therapy with nusinersen and AVXS-101 in SMA type 1
Lee BH, Collins E, Lewis L, et al.
Neurology, 2019
Permalink![]()
Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy
Ke Q, Zhao ZY, Mendell JR, et al.
World journal of pediatrics : WJP, 2019
Permalink![]()
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
Wolfe GI, Kaminski HJ, Aban IB, et al.
The Lancet. Neurology, 2019, 18, 3, p 259
Permalink![]()
Health profile of a cohort of adults with Duchenne muscular dystrophy
Pandya S, James KA, Westfield C, et al.
Muscle & Nerve, 2018
Permalink![]()
Application of the International Classification of Functioning, Disability and Health system to symptoms of the Duchenne and Becker muscular dystrophies
Conway KM, Ciafaloni E, Matthews D, et al.
Disability and rehabilitation, 2018, 40, 15, p 1773
Permalink![]()
Bone Health and Endocrine Care of Boys with Duchenne Muscular Dystrophy: Data from the MD STARnet
Weber DR, Weber DR, Thomas S, et al.
Journal of Neuromuscular Diseases, 2018, 5, 4, p 497
Permalink![]()
Diagnostic Accuracy of Phenotype Classification in Duchenne and Becker Muscular Dystrophy Using Medical Record Data
Andrews JG, Andrews JG, Lamb MM, et al.
Journal of Neuromuscular Diseases, 2018, 5, 4, p 481
Permalink![]()
An Update: Myasthenia Gravis and Pregnancy
Hamel J, Ciafaloni E
Neurologic clinics, 2018, 36, 2, p 355
Permalink![]()
Evidence in focus: Nusinersen use in spinal muscular atrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Michelson D, Ciafaloni E, Ashwal S, et al.
Neurology, 2018, 91, 20, p 923
Permalink![]()
Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy
Veerapandiyan A, Veerapandiyan A, Pal R, et al.
Neurology, 2018, 91, 7
Permalink![]()
Implementation of Duchenne Muscular Dystrophy Care Considerations
Andrews JG, Conway K, Westfield C, et al.
Pediatrics, 2018, 142, 1
Permalink![]()
A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial
Crow RA, Hart KA, McDermott MP, et al.
Trials, 2018, 19, 1
Permalink![]()
Developing standardized corticosteroid treatment for Duchenne muscular dystrophy
Guglieri M, Bushby K, McDermott MP, et al.
Contemporary clinical trials, 2017, 58, p 34
Permalink![]()
Perceived quality of life among caregivers of children with a childhood-onset dystrophinopathy: a double ABCX model of caregiver stressors and perceived resources
Frishman N, Conway KC, Andrews J, et al.
Health and quality of life outcomes, 2017, 15, 1
Permalink![]()
Secondary Conditions Among Males With Duchenne or Becker Muscular Dystrophy
Latimer R, Street N, Conway KC, et al.
Journal of child neurology, 2017, 32, 7, p 663
Permalink